Market Overview

UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Varian Medical Systems

Related VAR
Benzinga's M&A Chatter for Wednesday December 17, 2014
Doctors at Innovative Cancer Institute In Miami Use New Radiosurgery System To Treat Tumor Encroaching On Patient's Spinal Cord

In a report published Friday, Jefferies & Company reiterated its Buy rating on Varian Medical Systems (NYSE: VAR), and raised its price target from $65.00 to $68.00.

Jefferies noted, “VAR posted a strong F4Q with beats in revenues, EPS, and orders. Initial F13 guidance calls for 8-9% top-line growth. The strong surge in orders and higher outlook should ease persistent concerns of pressures from potential CMS reimbursement cuts, pricing, and competition.”

Varian Medical Systems closed on Thursday at $58.10.

Latest Ratings for VAR

DateFirmActionFromTo
Oct 2014JP MorganMaintainsOverweight
Oct 2014JefferiesMaintainsBuy
Jul 2014JefferiesMaintainsBuy

View More Analyst Ratings for VAR
View the Latest Analyst Ratings

Posted-In: Jefferies & CompanyAnalyst Color Price Target Analyst Ratings

 

Related Articles (VAR)

Around the Web, We're Loving...

Get Benzinga's Newsletters